Takeda signs licensing agreement on celiac candidate
![Takeda has now gotten hands on its third celiac treatment candidate](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14520554.ece/ALTERNATES/schema-16_9/takeda.jpg)
An existing partnership between two German companies, Zedira and Dr. Falk Pharma, is now welcoming a third partner, Japanese pharmaceutical company Takeda, into their midst, the latter announces in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
CHMP recommends approval of 10 drugs at October meeting
For subscribers
Takeda's profit shrank in Q1
For subscribers